Production of Nervonic acid in Brassica carinata for Industrial and

Transcription

Production of Nervonic acid in Brassica carinata for Industrial and
Production of Nervonic acid
in Brassica carinata
for Industrial and Health Applications
Elizabeth-France Marillia & David C.Taylor
ACRD-NRC
April 2014
Bio-Based Specialized Chemicals Program-ACRD
Overview
• NRC and its new RTO structure & mandate
• Life Science programs and industrial oils at NRC
• Nervonic acid: functions, uses and production
• Production in Brassica carinata: a Proof of Concept
• Future steps and collaboration with the industry
2
Saskatoon
About NRC
IRAP
• 2012-13 budget: $774M
Research
facilities
• Over 4,000 employees and
650 volunteer and independent visitors
• Wide variety of disciplines and broad array of services
and support to industry
3
New Research Technology
Organization (RTO) model
• Vision:
oTo be the most effective research and technology
organization in the world and stimulate sustainable
domestic prosperity
• Mission:
oWork with clients and partners to provide innovation
support, strategic research and technical services (fee for
services).
oBe dedicated to building economic competitiveness and
improving national productivity
4
NRC Life Sciences Research
Life Sciences
Aquatic and Crop
Resource Development
Human Health
Therapeutics
National Research
 Natural Health Products
 Algal Carbon Capture
 Wheat
 Bio-based Specialty Chemicals
 Crop Platform Technologies
 Biologics
 Vaccines
Medical Devices
NATURAL HEALTH PRODUCTS
5
Oil Seed Crops at NRC
From Arabidopsis to Canola to Brassica carinata....
30+ years of R&D on industrial oils and their applications
Source: Wikipedia
6
Nervonic Acid
24:1 15 (cis-tetracos-15- enoic acid) -9
Produced by elongation of erucic acid 22:1
Physiological Functions
• Physiological activity of nervonic acid discovered only 35 years ago
• Necessary for development and maintenance of brain tissue &
function:
o Component of myelin sheath. Serves to speed conduction of
nerve impulses
o Maintains integrity & regulates function of Ca2+ ion channeling in
cell membranes of nerve tissues
o Thought to play a major role in memory
o Role in postponing senility ?
Pharmacological Indications
Symptomatic treatment of:
• De-myelinating diseases: Multiple Sclerosis, Parkinson, ALD
• Schizophrenia: nervonic acid levels low in these patients
• Deficiencies associated w neurological disorders: Alzheimer’s
• HIV ? Nervonic acid inhibits HIV-1 Reverse Transcriptase
• Many applications in nutritional markets (senility, memory aid etc.)
• Treatments of arthritis, liver diseases and obesity
Dietary Supplements
• Babies/infants during the myelinating age. Baby foods/formulas
(Hangzhou Sweetant Biotech)
• Pre-term babies, no longer benefiting from maternal nutritionPregnant/lactating women
• High-level training adults/athletes: enriched energy
supplements with neuro-protective effect
.
10
Industrial Applications
1- Biofuels & Surfactants
• Next generation of alternative fuels:
ARA Biofuels ISOCONVERSION: ReadiJet, Readi Diesel.
Test flight with NRC in 2012
• “Green Surfactants”:
Enhance Oil Recovery (EOR) for crude oil (Oil Chem
Technologies). VLCFAs feedstocks used to reduce water &
energy consumption during bitumen recovery & processing
11
Industrial Applications
2- Bioplastics and Polymers
• Specialized polyamides, polyesters, polyols:
Feedstock for diacid production in the bioplastic
industry (Phytowelt Green Technologies; Mitsubishi)
• Paving bed polymers (low temp. stabilization):
Feedstock for moisture displacement additives in
asphalt paving sealers (SWEPCO)
12
Others Industrial Applications
Source Globalgrind
• Cosmetics; hair dyeing; nail varnish (L’Oreal, Novance)
• Medical: biological diagnosis (Konica); improved vaccine
composition (Eurocine vaccines);
• Photosensitive semiconductors (Samsung); superconductive
wire (Hitachi)
• Gels and films (YOUTEC)
• Recording medium (HP)
• Coating oil (Nalso) and ink (JNC)
13
Natural Sources for Nervonic Acid
Nervonic acid content (mg/100g)
Plant sources
Brassica oilseeds
Flaxseed
Sesame seeds
Macademia nuts
Tropaeolum speciosum
Lunaria (money plant)
Cardamine graeca
Acer (Purpleblow maple)
Borage
Sinapis alba
Hemp
69-83
64
35
18
10
8
5.4
2.3
Indigofera tinctoria (indigo)
Animal sources
King Salmon (Chinook)
Sockeye salmon
Cerebroside extracts
Pseudaxinella cf. lunaecharta
14
140
40
Nervonic Acid Suppliers and Market Values
Some Examples
Suppliers
Product
Market value
US$/Kg
Shanghi Soyoung
Biotechnology
nervonic acid food
additives
1-27
Shaanxi Pioneer Biotech Co natural nervonic acid
300-400
Wuxi Cima Science Co
10-1000
nervonic acid powder
Hangzhou Boduo Industrial
nervonic acid capsules
Trade Co
15
1500-2000
Production of Nervonic Acid in Brassica
Rationale:
High Erucic Acid (HEA) Brassica oilseeds contain traces of 24:1 in the
seed oil because of…... the absence of an elongase (KCS condensing
enzyme) specific for converting 22:1 to 24:1.
Goal:
Isolation & characterization of key gene(s) for the production of high
levels of nervonic acid in Brassica oilseed platform crops
Target KCS Gene Source
Cardamine graeca (bittercress)
15cm
1 cm
1 mm
The seed oil has 43 to 54% nervonic acid
Expression of C. graeca KCS in
Brassica carinata
NAPIN
CG KCS
transform
NOS
Brassica carinata
[ Ethiopian mustard ]
Why B. carinata?
● Excellent “vehicle crop” for HEA Brassica work;
22:1 ca 35-38%; 30% oil; Yields 2,500 kg / ha
● Highly transformable (up to 50%)
● Low out-crossing
● Highly resistant to fungal diseases; weed tolerant
● Suitable for growth in drier regions
Confined Field Trials (Saskatchewan)
% 18:1c9
% 20:1c11
% 22:1c13
% 24:1c15
45.00
40.00
35.00
30.00
25.00
20.00
15.00
10.00
5.00
0.00
Card KCS: B car Transgenics
CONTROLS
MUFAs in B. carinata transformants
Wild Type Control
18:1
20:1
22:1
Transgenic Control
24:1
Cardamine B. carinata
Transgenic Line
45% 24:1
Oil retains essential FAs: 25-30% -3 (18:3) + -6 (18:2)
Mono-Unsaturated FAs Elongation
What we can do in a Brassica industrial platform crop
18:1
20:1
22:1
24:1
26:1
FA: oleic
eicosenoic
erucic
nervonic
ximenic
Source:
Teesdalia
Crambe
Cardamine
Confidential
NRC IP:
Patent
Patent
Patent
PSIA
28:1 ?
Ability to tailor oil profiles for specific industrial & health applications
21
Uses of Industrial Oilseeds
B carinata VLCFA OILS & APPLICATIONS
VLCFA
20:1c11
22:1c13
24:1c15
26:1c17
JET FUELS
EOR
BIOPLASTICS
NEURO HEALTH
Future steps and collaborations
23
Next generation:
Ultra-High Nervonic Carinata (UHN) oil
What do we have?
High-Nervonic carinata line: ~45% nervonic acid
and essential FA profile of WT
17 g/100g seed; > any other seed source (~0.08g)
Market demand ?
An improved UHN carinata line (>80% 24:1)
Why?
Less purification required for industrial
applications where high PUFAs not desired
How?
Produce seed oils (TAG) with nervonic moieties
at all 3 sn- positions on the glycerol backbone
Tri- nervonoyl TAG
sn-1
Nervonic
sn-2
Nervonic
sn-3
25
Nervonic
Additional Genetic Modifications
to Achieve Commercial Success
•Over-express LPAT2 for esterification at the sn2 position
•Health applications: reduce residual erucic acid from 7% to
<2% ? or start with a low erucic B carinata?
•Industrial applications: silence endogenous B carinata KCS
and over-express KCS genes from Teesdalia (20:1) and
Cardamine (24:1) in tandem?
26
Mono-Unsaturated FAs Elongation
18:1
27
20:1
FA:
eicosenoic
Source:
Teesdalia
22:1
erucic
24:1
nervonic
Cardamine
Industrial Partnerships
What we need to achieve together:
•Identify & understand industry demand: needs, characteristics, trends
•Establish applied research collaborations:
oIdentify partners with complementary R&D for developing valueadded products
oForm strong collaboration and together take research from the lab
to the market
28
Thank you
Elizabeth-France Marillia
Scientist
Tel: 306-975-5282
Elizabeth.marillia@nrc-cnrc.gc.ca
www.nrc-cnrc.gc.ca
29
David C. Taylor
Laurel O’ Connor
Scientist
Client Relationship Leader
Tel: 306-975-5270
Tel: 306-975-4573
David.taylor@nrc-cnrc.gc.ca Laurel.oconnor@nrc-cnrc. gc.ca